new prescribing restrictions for rosiglitazone

Health Canada is announcing new prescribing restrictions for rosiglitazone (Avandia, Avandamet, and Avandaryl).

Rosiglitazone will no longer be approved for monotherapy...or in combination with a sulfonylurea...UNLESS metformin is NOT an option.

Health Canada's new labelling changes will also say not to use rosiglitazone in patients with ANY stage of heart failure.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote